【简介】博士后招聘网整理分享“新加坡分子肿瘤研究所分子生物学或生物化学方向博士后职位”，浏览查询更多博士后招聘计划请访问博士后招聘网。

The IFOM-p53Lab Joint Research Laboratory is a new initiative established by the ItalianFIRC Institute of Molecular Oncology (IFOM) and the Agency for Science and Technology of Singapore (A*STAR). The IFOM-p53Lab Joint Research Laboratory will serve as a key platform for scientific exchange and interactions between IFOM and A*STAR, offering postdoctoral fellows a unique opportunity to work with key scientists from both the IFOMand A*STAR campuses. The lab is located in A*STAR Biopolis in Singapore. The activities of the IFOM-p53Lab Joint Research Laboratory will focus on identifying novel targeted therapies against cancer.

The successful candidate will develop new tools to identify synthetic lethal pathways in tumor cells with compromised DNA repair signaling pathways. Promising anticancer targets should be further characterized using in vivo mouse models.

We are looking for highly motivated individuals, to lead projects and develop new experimental approaches. Applicants should hold a PhD in molecular & cellular biology or biochemistry and preferably have some experience with in vivo mouse xenograft models. The applicant must have a solid background in experimental research, particularly in molecular and cellular biology, a proven track record of outstanding scientific publications and a strong interest in molecular medicine and cancer target validation approaches. Candidates need to be highly organized and focused and be able to co-operate with other members of the research team. Excellent communication skills are required.

The terms of employment are initially for 3 years, and salary for the position will be negotiated based on the qualities and the relevant experience of the candidate.

请您在邮件申请时在标题注明信息来自：博士后招聘网-boshihoujob.com，电话咨询时说明从博士后招聘网(www.boshihoujob.com)看到的博士后招聘信息。

声明：凡本网注明“来源：XXX”的文/图等稿件，本网转载出于传递更多信息及方便产业探讨之目的，并不意味着本站赞同其观点或证实其内容的真实性，文章内容仅供参考。如其他媒体、网站或个人从本网站转载使用，须保留本网站注明的“来源”，并自负版权等法律责任。作者如果不希望被转载或者联系转载等事宜，请与我们联系。邮箱：boshihoujob@163.com。